Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of rituximab in refractory RRMS.
Durozard P, Maarouf A, Boutiere C, Ruet A, Brochet B, Vukusic S, Carra-Dalliere C, Labauge P, Mathey G, Debouverie M, Papeix C, Maillart E, Lubetzki C, Bensa C, Gout O, Giannesini C, Stankoff B, Ciron J, Brassat D, Pelletier J, Rico Lamy A, Audoin B. Durozard P, et al. Mult Scler. 2019 May;25(6):828-836. doi: 10.1177/1352458518772748. Epub 2018 May 3. Mult Scler. 2019. PMID: 29722639
Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy.
Rico A, Ninove L, Maarouf A, Boutiere C, Durozard P, Demortiere S, Saba Villarroel PM, Amroun A, Fourié T, de Lamballerie X, Pelletier J, Audoin B. Rico A, et al. Among authors: durozard p. Mult Scler J Exp Transl Clin. 2021 Nov 29;7(4):20552173211062142. doi: 10.1177/20552173211062142. eCollection 2021 Oct. Mult Scler J Exp Transl Clin. 2021. PMID: 34925877 Free PMC article.
Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity?
Poullet Z, Pique J, Maarouf A, Boutiere C, Rico A, Demortiere S, Durozard P, Papeix C, Maillart E, Collongues N, Ayrignac X, Zephir H, Deschamps R, Ciron J, Pelletier J, Marignier R, Audoin B. Poullet Z, et al. Among authors: durozard p. Neurol Neuroimmunol Neuroinflamm. 2022 Apr 26;9(4):e1167. doi: 10.1212/NXI.0000000000001167. Print 2022 Jul. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35473885 Free PMC article.
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception.
Demortiere S, Maarouf A, Rico A, Boutiere C, Hilezian F, Durozard P, Pelletier J, Audoin B. Demortiere S, et al. Among authors: durozard p. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 7;10(5):e200161. doi: 10.1212/NXI.0000000000200161. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37550074 Free PMC article.
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Claverie R, Perriguey M, Rico A, Boutiere C, Demortiere S, Durozard P, Hilezian F, Dubrou C, Vely F, Pelletier J, Audoin B, Maarouf A. Claverie R, et al. Among authors: durozard p. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 21;10(5):e200152. doi: 10.1212/NXI.0000000000200152. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37604695 Free PMC article.
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study.
Berthet E, Guillonnet A, Houillier C, Ursu R, Soussain C, Touat M, Gueguen A, de Renzis B, Bigaut K, Ahle G, Durozard P, Grosset-Janin D, Oberic L, Bonnet A, Grandjean AP, Moluçon-Chabrot C, Hoang-Xuan K, Chabriat H, Guey S. Berthet E, et al. Among authors: durozard p. Ann Neurol. 2024 Nov 28. doi: 10.1002/ana.27132. Online ahead of print. Ann Neurol. 2024. PMID: 39605186
13 results